Streetbeat News

Products Services

MBOT

Microbot Medical has entered Phase 2 of its collaboration with Corewell Health to advance remote telesurgery using the LIBERTY Endovascular Robotic System, following successful Phase 1 results.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:31 pm

AVGO

GOOG

GOOGL

META

Broadcom Inc. (NASDAQ:AVGO) has secured major AI ASIC program wins with OpenAI, Google, and Meta, positioning itself as a leader in the AI semiconductor market. These partnerships are expected to significantly boost Broadcom's revenue, tapping into a $150 billion AI opportunity over the next five years.

Portfolio Pulse from Surbhi Jain

August 22, 2024 | 12:26 pm

PLTR

Palantir Technologies has hired former Rep. Mike Gallagher to lead its defense business, aiming to boost U.S. government contract growth. Gallagher, known for his strong stance against China, aligns with Palantir's strategic focus on defense and innovation.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:22 pm

AIRI

MOBX

VRAX

Air Industries Group (AIRI) shares surged 78% after securing a $110 million contract for Thrust Struts production. Mobix Labs (MOBX) shares rose 165% following a positive Q3 financial report. Virax Biolabs (VRAX) shares fell 10% as the company announced a $5M stock offering.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:19 pm

RZLV

Rezolve AI has partnered with ePages to enhance the eCommerce experience for small and medium-sized businesses (SMBs) in Europe. This collaboration will provide AI-driven interaction and multilingual virtual support in 95 languages.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:12 pm

BTCUSD

Macro analyst Lyn Alden views Bitcoin as a standout asset amid global currency debasement, despite recent sideways trading due to flat global liquidity. She anticipates a positive outlook for Bitcoin by 2025, driven by potential easing of monetary policy and technological advancements.

Portfolio Pulse from Khyathi Dalal

August 22, 2024 | 12:12 pm

EGIO

Edgio has become the first CDN to implement MAUD technology, collaborating with BT Group to trial EE TV content delivery. This initiative aims to offer lower costs, higher quality, and greener streaming, marking the first live CDN deployment of MAUD technology.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:09 pm

REPL

Replimune Group, Inc. (NASDAQ:REPL) announced that its IGNYTE clinical trial's primary analysis will be presented at the ESMO Congress 2024, highlighting its novel oncolytic immunotherapies.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:08 pm

STRO

Sutro Biopharma has initiated a Phase 2 trial for its drug luvelta targeting non-small cell lung cancer. The trial is open for enrollment, with initial data expected in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:08 pm

SKYE

Skye Bioscience shares rose as the company began screening patients for a Phase 2 clinical trial of nimacimab.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:06 pm